FDA Warns of Compounding Pharmacy's Products

The agency recommended that Park Compounding Pharmacy cease sterile operations and recall all non-expired sterile drug products; the company agreed to halt sterile operations but not to the recall.

FDA announced that its investigators observed insanitary conditions, including poor sterile production practices, during a recent inspection of Park Compounding Pharmacy's facility, saying this raised concerns about the company's ability to assure the sterility of drug products that it produced. So the agency has issued a warning to alert health care professionals and patients not to use drug products intended to be sterile made and distributed by Chen Shwezin Inc., doing business as Park Compounding Pharmacy, in Westlake Village, Calif.

FDA on Sept. 29 recommended that Park Compounding Pharmacy cease sterile operations until adequate corrections are made and recall all of its non-expired sterile drug products. On Sept. 30, the company "informed FDA that it has agreed to cease sterile operations, but the company has refused to recall its products," according to the FDA, which reported it is not aware of any adverse event associated with the use of products from Park Compounding Pharmacy.

Patients who have received drug products produced by Park Compounding Pharmacy and have concerns about them should contact their health care professional, according to the agency, which recommends that health care professionals immediately check their medical supplies, quarantine any sterile drug products from Park Compounding Pharmacy, and not administer them to patients.

FDA's MedWatch safety alert is available here.

Download Center

  • OSHA Recordkeeping Guide

    In case you missed it, OSHA recently initiated an enforcement program to identify employers who fail to electronically submit Form 300A recordkeeping data to the agency. When it comes to OSHA recordkeeping, there are always questions regarding the requirements and ins and outs. This guide is here to help! We’ll explain reporting, recording, and online reporting requirements in detail.

  • Incident Investigations Guide

    If your organization has experienced an incident resulting in a fatality, injury, illness, environmental exposure, property damage, or even a quality issue, it’s important to perform an incident investigation to determine how this happened and learn what you can do to prevent similar incidents from happening in the future. In this guide, we’ll walk you through the steps of performing an incident investigation.

  • Lone Worker Guide

    Lone workers exist in every industry and include individuals such as contractors, self-employed people, and those who work off-site or outside normal hours. These employees are at increased risk for unaddressed workplace accidents or emergencies, inadequate rest and breaks, physical violence, and more. To learn more about lone worker risks and solutions, download this informative guide.

  • Job Hazard Analysis Guide

    This guide includes details on how to conduct a thorough Job Hazard Analysis, and it's based directly on an OSHA publication for conducting JHAs. Download the guide to learn how to identify potential hazards associated with each task of a job and set controls to mitigate hazard risks.

  • The Basics of Incident Investigations Webinar

    Without a proper incident investigation, it becomes difficult to take preventative measures and implement corrective actions. Watch this on-demand webinar for a step-by-step process of a basic incident investigation, how to document your incident investigation findings and analyze incident data, and more. 

  • Vector Solutions

OH&S Digital Edition

  • OHS Magazine Digital Edition - November December 2022

    November December 2022

    Featuring:

    • IH: GAS DETECTION
      The Evolution of Gas Detection
    • OSHA TOP 10
      OSHA's Top 10 Most Frequently Cited Standards for FY 2022
    • FALL PROTECTION
      Enhance Your Fall Protection Program with Technology
    • 90TH ANNIVERSARY
      The Future: How Safety WIll Continue to Evolve
    View This Issue